Status: current, Primitive. Date: 31-Jul 2005. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1612851000168111 | Drotrecogin alfa (activated) | en | Synonym | Active | Case insensitive | SNOMED Clinical Terms Australian extension |
| 2546678017 | Drotrecogin alfa activated (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 2548981015 | Drotrecogin alfa activated | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Drotrecogin alfa (activated) | Is a | Recombinant human activated protein c | true | Inferred relationship | Some | ||
| Drotrecogin alfa (activated) | Has disposition | Activated coagulation factor | true | Inferred relationship | Some | ||
| Drotrecogin alfa (activated) | Is a | Protein C (activated) | false | Inferred relationship | Some | ||
| Drotrecogin alfa (activated) | Has disposition | Coagulation factor inhibitor | false | Inferred relationship | Some | ||
| Drotrecogin alfa (activated) | Has disposition | Protease inhibitor protein | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Drotrecogin alfa (activated) | Has active ingredient | False | Drotrecogin alfa (activated) | Inferred relationship | Some | |
| Drotrecogin alfa (activated) 5mg powder for infusion solution vial | Has active ingredient | False | Drotrecogin alfa (activated) | Inferred relationship | Some | |
| Drotrecogin alfa 20 mg powder for solution for injection vial | Has active ingredient | False | Drotrecogin alfa (activated) | Inferred relationship | Some |
Reference Sets
Substance foundation reference set
FHIR